Dana-Farber, BrainStorm partner for stem cell trial

04/10/2013 | Pharmaceutical Business Review Online

Dana-Farber Cancer Institute will provide production facilities for BrainStorm Cell Therapeutics' NurOwn stem cell product for use in an upcoming midstage trial. The study will begin this year at the Mayo Clinic, Massachusetts General Hospital and University of Massachusetts Hospital.

View Full Article in:

Pharmaceutical Business Review Online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Teaching Associate (Hospitality Management)
University of Illinois at Urbana-Champaign
Urbana, IL
Director, Global Regulatory Affairs
Rodan and Fields, LLC
San Francisco, CA